168 related articles for article (PubMed ID: 30825298)
1. Dynamic visualization of the whole process of cytotoxic T lymphocytes killing B16 tumor cells in vitro.
Qi S; Shi H; Liu L; Zhou L; Zhang Z
J Biomed Opt; 2019 Mar; 24(5):1-7. PubMed ID: 30825298
[TBL] [Abstract][Full Text] [Related]
2. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy.
Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH
Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604
[TBL] [Abstract][Full Text] [Related]
3. Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells.
Crowley NJ; Vervaert CE; Seigler HF
Cancer Res; 1992 Jan; 52(2):394-9. PubMed ID: 1728411
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T Lymphocytes Control Growth of B16 Tumor Cells in Collagen-Fibrin Gels by Cytolytic and Non-Lytic Mechanisms.
Majumder B; Budhu S; Ganusov VV
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515143
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocytes generated by short-term in vitro TCR stimulation in the presence of IL-4 are therapeutically effective against B16 melanoma.
Chang ML; Chen YT; Su YC; Kung JT
J Biomed Sci; 2003; 10(6 Pt 1):644-50. PubMed ID: 14576467
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH
Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534
[TBL] [Abstract][Full Text] [Related]
7. Reduced CTL motility and activity in avascular tumor areas.
Manaster Y; Shipony Z; Hutzler A; Kolesnikov M; Avivi C; Shalmon B; Barshack I; Besser MJ; Feferman T; Shakhar G
Cancer Immunol Immunother; 2019 Aug; 68(8):1287-1301. PubMed ID: 31253998
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.
Verra NC; Jorritsma A; Weijer K; Ruizendaal JJ; Voordouw A; Weder P; Hooijberg E; Schumacher TN; Haanen JB; Spits H; Luiten RM
Cancer Res; 2004 Mar; 64(6):2153-61. PubMed ID: 15026357
[TBL] [Abstract][Full Text] [Related]
9. Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy.
Lu D; Wang Y; Zhang T; Wang F; Li K; Zhou S; Zhu H; Yang Z; Liu Z
J Nanobiotechnology; 2021 Jun; 19(1):175. PubMed ID: 34112200
[TBL] [Abstract][Full Text] [Related]
10. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
Sun L; Guo H; Jiang R; Lu L; Liu T; He X
Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of the therapeutic effectiveness of EBV-LMP2 recombinant adenovirus vaccine in nasopharyngeal carcinoma.
Ge Y; Zhou Z; Wang X; Zhou Y; Liu W; Teng Z; Zeng Y
Biomed Pharmacother; 2020 Jan; 121():109626. PubMed ID: 31743878
[TBL] [Abstract][Full Text] [Related]
12. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.
Oflazoglu E; Elliott M; Takita H; Ferrone S; Henderson RA; Repasky EA
J Transl Med; 2007 Jun; 5():29. PubMed ID: 17592641
[TBL] [Abstract][Full Text] [Related]
13. Defects in the acquisition of tumor-killing capability of CD8+ cytotoxic T cells in streptozotocin-induced diabetic mice.
Chen SC; Su YC; Lu YT; Ko PC; Chang PY; Lin HJ; Ho HN; Lai YP
PLoS One; 2014; 9(11):e109961. PubMed ID: 25390652
[TBL] [Abstract][Full Text] [Related]
14. A single bout of dynamic exercise enhances the expansion of MAGE-A4 and PRAME-specific cytotoxic T-cells from healthy adults.
LaVoy EC; Bollard CM; Hanley PJ; Blaney JW; O'Connor DP; Bosch JA; Simpson RJ
Exerc Immunol Rev; 2015; 21():144-53. PubMed ID: 25826370
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
16. Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice.
Breart B; Lemaître F; Celli S; Bousso P
J Clin Invest; 2008 Apr; 118(4):1390-7. PubMed ID: 18357341
[TBL] [Abstract][Full Text] [Related]
17. Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver.
Liu L; Dai B; Li R; Liu Z; Zhang Z
Theranostics; 2021; 11(1):194-208. PubMed ID: 33391470
[TBL] [Abstract][Full Text] [Related]
18. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
[TBL] [Abstract][Full Text] [Related]
19. Multiphoton imaging of cytotoxic T lymphocyte-mediated antitumor immune responses.
Boissonnas A; Scholer-Dahire A; Fetler L; Amigorena S
Curr Top Microbiol Immunol; 2009; 334():265-87. PubMed ID: 19521689
[TBL] [Abstract][Full Text] [Related]
20. Culturing CTLs under Hypoxic Conditions Enhances Their Cytolysis and Improves Their Anti-tumor Function.
Gropper Y; Feferman T; Shalit T; Salame TM; Porat Z; Shakhar G
Cell Rep; 2017 Sep; 20(11):2547-2555. PubMed ID: 28903036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
